The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced an investment of approximatel...
Swedish firm BioArctic AB's partner Eisai has announced that LEQEMBI (lecanemab) will be launched in Japan&nbs...
Interactomics pioneer Depixus, based in Paris, has entered a collaboration with Daiichi Sankyo to use their novel MAGNA ...
Leading GMP cell CDMO I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therap...
Indian firm Meril Life Sciences has signed an agreement with Japan’s leading cardiovascular medtech company, Japan...
Japan-headquartered Fujifilm Corporation has announced the investment of $200 million in two subsidiaries to significant...
Dr. Bhatia Medical Coaching Institute (DBMCI) has announced a ground breaking joint venture with M3, Inc., a prominent J...
Japanese pharma major Eisai Co. has made an agreement to collaborate with the Department of Medical Services (DMS), Mini...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
Daiichi Sankyo has reached an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to supply the o...
Japan-based Fujitsu Limited and Delight Health, a Bay Area startup, have announced that Fujitsu will license its Topolog...
Japan-based Astellas Pharma and US-based startup Propella Therapeutics have entered into a merger agreement pursuant to ...
Japan-based University of Tsukuba and Astellas Pharma have signed a letter of confirmation regarding a strateg...
Japan-based iPark Institute has announced the signing of a groundbreaking business agreement with South Korea's Small an...
Japanese firm Fujitsu has signed a General Action Protocol with the Regional Government of Andalusia, Spain to establish...
Daiichi Sankyo Europe GmbH, the European headquarter organisation of the Japanese pharmaceutical company Daiichi Sankyo ...
Duke-NUS Medical School (Duke-NUS) in Singapore and IPGaia, Inc. (IPG) in Japan have signed an agreement to jointly adva...
Japan-headquartered Global Health Innovative Technology Fund (GHIT Fund) and Switzerland-based Medicines Patent Pool (MP...
